COVID-19 in patients with chronic myeloid leukaemia on tyrosine kinase inhibitor therapy: a Honduran observational study

INTRODUCTION: In the earliest cases of COVID-19, a higher percentage of severe and fatal cases was observed in patients with cancer, including those with haematological malignancies. However, patients with chronic myeloid leukaemia (CML) had better prognoses, suggesting that tyrosine kinase inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajardoa, Carlos J, Cálixb, Eda Sofía, Mojicac, Rafael, Duarted, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934964/
https://www.ncbi.nlm.nih.gov/pubmed/36819815
http://dx.doi.org/10.3332/ecancer.2022.1481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934964/
https://www.ncbi.nlm.nih.gov/pubmed/36819815
http://dx.doi.org/10.3332/ecancer.2022.1481

Ejemplares similares